A2BP1 anticorps (AA 151-250) (Biotin)

N° du produit ABIN717403

Cet anticorps Lapin Polyclonal détecte spécifiquement A2BP1 dans WB, ELISA, IHC (p) et IHC (fro). Il présente une réactivité envers Humain.

Aperçu rapide pour A2BP1 anticorps (AA 151-250) (Biotin) (ABIN717403)

Antigène: A2BP1 (Ataxin 2-Binding Protein 1 (A2BP1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp A2BP1 est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-A2BP1 anticorps (Biotin)

Épitope: AA 151-250

Homologie: Human,Mouse,Rat,Dog,Cow,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human A2BP1/Fox1

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur A2BP1

Antigène: A2BP1 (Ataxin 2-Binding Protein 1 (A2BP1))

Autre désignation: A2BP1

Sujet:

Synonyms: A2 BP1, A2BP 1, A2BP, A2BP1, Ataxin 2 binding protein 1, Ataxin-2-binding protein 1, Ataxin2 binding protein 1, FOX 1, Fox-1 homolog A, FOX1, RFOX1_HUMAN, Hexaribonucleotide binding protein 1, Hexaribonucleotide-binding protein 1, HRNBP 1, HRNBP1.

Background: RNA-binding protein that regulates alternative splicing events by binding to 5'-UGCAUGU-3' elements. Regulates alternative splicing of tissue-specific exons and of differentially spliced exons during erythropoiesis.Predominantly expressed in muscle and brain.